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Abstract: Flexible in vitro translation (FIT) was used as a screening method to uncover a new
methodology for peptide constraining based on the attack of a nucleophilic side-chain functionality
onto an oxidized furylalanine side chain. A set of template peptides, each containing furylalanine as
furan-modified amino acid and a nucleophilic residue (Cys, His, Lys, Arg, Ser, or Tyr), was produced
through FIT. The translation mixtures were treated with N-bromosuccinimide (NBS) to achieve
selective furan oxidation and subsequent MALDI analysis demonstrated Lys and Ser as promising
residues for cyclisation. Solid-phase peptide synthesis (SPPS) was used to synthesize suitable amounts
of material for further in-depth analysis and characterisation. It was found that in the case of the
peptide containing lysine next to a furylalanine residue, a one-pot oxidation and reduction reaction
leads to the generation of a cyclic peptide featuring a pyrrole moiety as cyclisation motif, resulting
from the attack of the lysine side chain onto the oxidized furylalanine side chain. Structural evidence
was provided via NMR and the generality of the methodology was explored. We hereby expand the
scope of our previously developed furan-based peptide labeling and crosslinking strategy.
Keywords: constrained peptides; flexible in vitro translation; furan oxidation; peptide cyclisation
1. Introduction
From a pharmaceutical perspective, peptides occupy a transition zone between small molecule
chemicals and larger biologics [1]. Compounds in this intermediate size range can theoretically
combine the advantages of biologics (e.g., the specificity of monoclonal antibodies and their ability
to disrupt protein-protein interactions) with the desirable aspects of small molecule drugs (e.g., oral
availability and biostability). In particular, relatively small peptides (up to ~15 amino acids) constrained
through cyclizing linkages are capable of interfering with protein–protein interactions, exhibit high
target specificity, and can be highly resistant to serum proteases, and yet are small enough to be orally
available and avoid immune responses [1,2]. For these reasons, several constrained peptides are used
as therapeutics [1] (e.g., octreotide, cyclosporine A, nisin) and more are in late-stage clinical trials [2].
Moreover, new approaches for constraining the inherently flexible conformation of short peptides are
highly sought after and form a subject of continuous investigation.
From an organic synthetic perspective, constraining peptide structure can be achieved in
numerous ways. Four conceptually different approaches can be adopted to obtain cyclic peptides [1],
depending on the functional groups present in the side chains of the envisaged sequence: head-to-tail,
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head-to-side-chain, side-chain-to-tail, and side-chain-to-side-chain connection. In this way, not only
head-to-tail cyclic peptide construction but also loop stabilization and stabilization of alpha helices
through so-called peptide stapling can be achieved by creating covalent connections between two of
the side chains of a specific peptide sequence. Methods can also be conceptually subdivided into
either two component systems, in which a bireactive external component is added to react with
two functional groups in the peptide (commonly side-chain moieties), or one-component systems,
in which two moieties in the peptide react to form a cyclizing link. When considering the specific
nature of the side-chain functionalities of the relevant amino acids, further distinctions can be drawn
based on whether two natural amino acid residues, one natural and one unnatural amino acid residue,
or two unnatural amino acids are involved in the reaction.
A number of chemistries used in two-component systems are based on the use of two unnatural
amino acids that react with double “click” linkers [3]. Alternatively, reactions using two canonical
amino acids include double thioether [4] linkages via reaction with Cys residues. Arylation [5] and
alkylation [6,7] chemistry on both Lys and Cys side chains have also been reported. In view of the
higher complexity of such two-component systems and the possibility for formation of regio-isomeric
products when applying unsymmetrical linker components, alternative, one-component systems have
been developed.
One-component approaches where two natural amino acids are involved in the peptide cyclisation
include lactam formation between Lys and Glu/Asp [8] and formation of a disulphide bridge between
two Cys residues [9] in addition to enzymatic cyclisation strategies, for example, between Lys
and Trp [10]. However, one-component systems employing two natural amino acids inherently
lack selectivity due to the possible presence of other natural residues in the sequence of interest.
Therefore, chemistries using two unnatural amino acids have been developed, including ring-closing
metathesis (RCM) hydrocarbon linkages [11], copper-catalysed azide alkyne click (CuAAC) [12]
reactions, alkene-tetrazole [13] cycloaddition, glaser coupling [14], and oxime formation [15]. It is,
however, not always straightforward to incorporate two unnatural amino acids in a peptide sequence.
Therefore, strategies using one unnatural and one naturally occurring amino acid functionality
(thereby combining a degree of selectivity with ease of synthesis) have gained increasing attention,
such as the formation of a thioether [16] between a specifically located Cys residue and a second
residue featuring an alkylating moiety, or peptide macrocyclization via reaction of a noncanonical
aldehyde moiety and the peptide N terminus [17].
In addition to the chemical peptide synthesis approaches discussed above, biotechnological
techniques for the generation of constrained peptides have recently been developed. In particular,
genetic code reprogramming approaches, such as flexible in vitro translation [18] (FIT), allow for the
incorporation of diverse unnatural amino acids into peptides synthesized ribosomally, thereby enabling
diverse one-component cyclizing chemistries in translated peptides [19–24]. In a FIT reaction, one or
more unnatural amino acids are aminoacylated onto specific tRNAs, which are then introduced into
a fully reconstituted in vitro translation reaction deficient for one or more natural amino acids. In this
way, specific unnatural amino acids of interest can be translated in place of their natural analogues.
The aminoacylation reaction itself is achieved through the use of flexizymes (flexible tRNA acylation
ribozymes), which catalyze the aminoacylation of tRNA 3′-terminal hydroxyls using an amino acid
substrate activated via an ester (or thioester) leaving group. This highly versatile approach has
been used for the synthesis of peptides containing diverse unnatural amino acids including multiple
cyclizing chemistries [19–24].
In the context of our previous work on furan-based peptide labeling [25,26] and peptide/protein
crosslinking [27], we became interested in exploiting FIT for the exploration of the potential utility of
furan side chains in a peptide-constraining context. To identify which of the canonical nucleophilic
amino acids is prone to react with an oxidized furan moiety, we made use of FIT to produce a set of
peptides encompassing both a furan amino acid and a nucleophilic amino acid that could potentially
react to form a side-chain-to-side-chain linked structure (Figure 1).
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Figure 1. Schematic overview of the objective of the flexible in vitro translation screening experiment. 
A set of peptides was produced by flexible in vitro translation (FIT) (A) all bearing a furan amino 
acid and a nucleophilic residue. In a second stage, the furan moiety was oxidized (B) and 
nucleophiles can potentially react with the keto-enal moiety. The peptides were analyzed via 
MALDI-TOF mass spectrometry to identify any formed constrained peptides (C). 
In the current work, we show that a furan amino acid can be incorporated via FIT and, 
following peptide translation, selective furan oxidation within the translated peptides can be 
achieved using N-bromosuccinimide (NBS). It was shown that upon NBS treatment, a Lys residue, 
occurring in the peptide sequence, induces formation of a cyclic imine at lower pH conditions. Upon 
reduction of the resulting conjugate, a pyrrole-containing cyclic peptide was isolated. We here 
provide structural evidence (NMR) for the formation of the pyrrole unit as a cyclisation motif and 
explore the generality of this new peptide-constraining methodology. 
2. Experimental Section 
2.1. Synthesis of Cyanomethyl Ester (CME)-Activated Amino Acid Substrates 
The synthesis of N-acetyl phenylalanine was reported previously (see Supplementary Materials 
Sections 2 and 12) [28]. For synthesis of CME-activated 2-furanyl alanine (see Supplementary 
Materials Section 1 for details), Boc-L-2-furylalanine. DCHA (1 part) was suspended in 5–10 volumes 
of cold t-butyl methyl ether. 10% of phosphoric acid was added under stirring until the 
dicyclohexylammonium (DCHA) salt was completely dissolved and two clear phases appeared. The 
pH of the lower aqueous phase was around 2–3. The organic phase was isolated and washed once 
with 2 volume parts of phosphoric acid 10% and 3 times with 2 volume parts of water. The pH of the 
aqueous phase was ≥4. TLC (2:1 hexane/EtOAc) was used to check whether the amino acid was 
liberated from its DCHA salt. The organic phase was dried over anhydrous sodium sulfate, filtered 
off, and evaporated to dryness in vacuo to obtain the free amino acid. Boc-L-2-furylalanine was 
dissolved in 300 μL of chloroacetonitrile, 1,2 eq of DIPEA was added, and the mixture was reacted 
overnight at room temperature. Completion of the reaction was followed by TLC (2:1 
hexane/EtOAc). The reaction mixture was transferred to a separation funnel of 100 mL and extracted 
with 50 mL of Et2O. The organic phase was washed with 3 × 50 mL of 1M HCl (aq), 2 × 50 mL with 
saturated NaHCO3 (aq), 2 × 10 mL with saturated NaCl (aq). The organic phase was dried over 
Na2SO4 and evaporated to dryness. Flash chromatography was used for purification of the 
compound (2:1 hexane/EtOAc). The collected fractions were evaporated to dryness. The purified 
compound was then dissolved in 4 M HCl/dioxane and stirred for 10 min on ice, followed by 30 min 
at room temperature. The reaction was followed by TLC (2:1 hexane/EtOAc). The reaction mixture 
was evaporated to almost complete dryness. Cold Et2O was added to precipitate the amino acid. The 
Boc-group was removed by dissolving the peptide in 4 M HCl/dioxane and keeping the solution on 
ice for 30 min. After reaction, the HCl/dioxane is partially removed by evaporation, with subsequent 
addition of cold diethylether to precipitate the amino acid. After centrifugation, the supernatant was 
discarded and the amino acid was obtained after drying in vacuo. 
Figure 1. Schematic overview of the objective of the flexible in vitro translation screening experiment.
A set of peptides was produced by flexible in vitro translation (FIT) (A) all bearing a furan amino acid
and a nucleophilic residue. In a second stage, the furan moiety was oxidized (B) and nucleophiles
can potentially react with the keto-enal moiety. The peptides were analyzed via MALDI-TOF mass
spectrometry to identify any formed constrained peptides (C).
In the current work, we show that a furan amino acid can be incorporated via FIT and, following
peptide translation, selective furan oxidation within the translated peptides can be achieved using
N-bromosuccinimide (NBS). It was shown that upon NBS treatment, a Lys residue, occurring in the
peptide sequence, induces formation of a cyclic imine at lower pH conditions. Upon reduction of
the resulting conjugate, a pyrrole-containing cyclic peptide was isolated. We here provide structural
evidence (NMR) for the formation of the pyrrole unit as a cyclisation motif and explore the generality
of this new peptide-constraining methodology.
2. Experimental Section
2.1. Synthesis of Cyanomethyl Ester (CME)-Activated Amino Acid Substrates
The synthesis of N-acetyl phenylalanine was reported previously (see Supplementary Materials
Sections 2 and 12) [28]. For synthesis of CME-activated 2-furanyl alanine (see Supplementary Materials
Section 1 for details), Boc-L-2-furylalanine. DCHA (1 part) was suspended in 5–10 volumes
of cold t-butyl methyl ether. 10% of phosphoric acid was added under stirring until the
dicyclohexylammonium (DCHA) salt was completely dissolved and two clear phases appeared.
The pH of the lower aqueous phase was around 2–3. The organic phase was isolated and washed once
with 2 volume parts of phosphoric acid 10% and 3 times with 2 volume parts of water. The pH of
the aqueous phase was ≥4. TLC (2:1 hexane/EtOAc) was used to check whether the amino acid was
liberated from its DCHA salt. The organic phase was dried over anhydrous sodium sulfate, filtered off,
and evaporated to dryness in vacuo to obtain the free amino acid. Boc-L-2-furylalanine was dissolved
in 300 µL of chloroacetonitrile, 1,2 eq of DIPEA was added, and the mixture was reacted overnight at
room temperature. Completion of the reaction was followed by TLC (2:1 hexane/EtOAc). The reaction
mixture was transferred to a separation funnel of 100 mL and extracted with 50 mL of Et2O. The organic
phase was washed with 3 × 50 mL of 1M HCl (aq), 2 × 50 mL with saturated NaHCO3 (aq), 2 × 10 mL
with saturated NaCl (aq). The organic phase was dried over Na2SO4 and evaporated to dryness.
Flash chromatography was used for purification of the compound (2:1 hexane/EtOAc). The collected
fractions were evaporated to dryness. The purified compound was then dissolved in 4 M HCl/dioxane
and stirred for 10 min on ice, followed by 30 min at room temperature. The reaction was followed by
TLC (2:1 hexane/EtOAc). The reaction mixture was evaporated to almost complete dryness. Cold Et2O
was added to precipitate the amino acid. The Boc-group was removed by dissolving the peptide in 4 M
HCl/dioxane and keeping the solution on ice for 30 min. After reaction, the HCl/dioxane is partially
removed by evaporation, with subsequent addition of cold diethylether to precipitate the amino acid.
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After centrifugation, the supernatant was discarded and the amino acid was obtained after drying
in vacuo.
2.2. Flexible In Vitro Translation
Flexizymes and tRNAs were synthesized as previously described [18]. Aminoacylation of the
elongator tRNA with furylalanine, 1 µL 500 mM HEPES-KOH buffer of pH 7.5, and 250 µM flexizyme
(eFx) and 250 µM tRNA were added to 3 µL of milliQ H2O. The mixture (6 µL total volume) was placed
in a heat block at 95 ◦C for 2 min. Afterwards, 2 µL 3M MgCl was added and the tube was mixed
well and placed at room temperature for 5 min. The tube was placed on ice for several minutes and
subsequently 2 µL of 25 mM furylalanine-CME (DMSO solution) was added. The solution was mixed
and incubated on ice for 6 h. For the aminoacylation of initiator tRNA with N-acetylated phenylalanine,
the same protocol was used except for the final incubation time on ice, which was 2 h. After EtOH
precipitation of aminoacyl-tRNA, the mixture was divided in two (5 µL each). Then, 20 µL of 0.3 M
NaOAc and 50 µL of EtOH were added and the solution was mixed well. The solution was centrifuged
at 13 krpm, 25 ◦C for 15 min, and the supernatant was discarded. Next, 30 µL of 70% EtOH containing
0.1 M NaOAC (pH 5.2) was added to the pellet and vortexed for 10 s, centrifuged for 5 min, and the
supernatant was discarded. This last step was repeated and finally 20 µL of 70% EtOH was added and
the sample was centrifuged for 3 min. The supernatant was discarded, the lid was opened, and the
tube was covered with a clean paper towel and the sample was left to dry for 5–10 min.
Genetically reprogrammed translation was performed in a FIT reaction at a final scale of 2.5 µL
at 37 ◦C for 30 min as previously described [18]. After translation, MALDI-TOF MS analysis was
performed as previously described [18] using an UltraFlex instrument (Bruker, Billerica, MA, USA).
2.3. Solid-Phase Peptide Synthesis
Peptides were synthesized using standard Fmoc chemistry on chlorotrityl resin
(see Supplementary Materials Sections 6 and 12). The automated peptide synthesis was performed
on either a MultiPep (Intavis, Tübingen, Germany) or Syro (Multisyntech, Witten, Germany) device.
Synthesis with double couplings was performed with HBTU as coupling reagent, 5 equivalents
amino acid and DIPEA in NMP as base. Fmoc deprotection was carried out with piperidine in
DMF. Following the automated peptide synthesis, the N-terminus was acetylated with a mixture
of 5% acetic acid anhydride and 6% 2,6-lutidine in DMF in a 30 min reaction at room temperature.
A mixture of 95% trifluoro acetic acid (TFA), 2.5% triisopropyl silane, and 2.5% H2O was used to
cleave the peptide from the resin. Peptides were subsequently precipitated in cold methyl tert-butyl
ether. Purification of the synthesized peptides was done on an Agilent 1100 Series HPLC instrument
equipped with a Phenomenex Luna C18(2) at 35 ◦C flow rate of 4.5 mL/min. The column was eluted
with a gradient from 100% H2O with 0.1% TFA to 100% acetonitrile in 20 min.
3. Results and Discussion
3.1. FIT-Based Synthesis of Furan-Modified Peptides
Taking advantage of the utility of FIT for the facile synthesis of diverse peptides at small
scale, a screening experiment was designed to identify amino acids able to react with an oxidized
(activated) furan amino acid. Commercially available furylalanine (Fua), which is isosteric with
His and isoelectronic with respect to Tyr, was selected as the furan-containing amino acid. For this
screening experiment, simple template peptides were designed containing no other reactive functional
groups aside from those functionalities to be examined for their capacity to intramolecularly react
with the (oxidized) furan moiety. Since the N-terminus is also a potential nucleophile and we were
interested in reactions of the oxidized furan moiety and the side chains of natural amino acids
(peptide-constraining) rather than head-to-side-chain macrocyclization, each peptide was translated
with an acetylated N-terminus through the use of N-acetyl Phe (AcF). To favour eventual cyclisation
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events by enhancing the proximity between the two reactive groups, a Pro residue was positioned in
between. The final template peptide sequence used was AcPheAlaGlyAlaFuaGlyProGlyXAlaGlyAla
with X being a natural residue featuring a nucleophilic side chain Cys, His, Lys, Arg, Ser, or Tyr.
FIT-mediated translation of peptides initiated with N-acetyl Phe has been described
previously [28], however, to the best of our knowledge, use of this approach for translation of Fua has
not been reported. To achieve this, cyanomethylester (CME)-activated Fua was synthesized starting
from boc-furylalanine, through esterification with chloroacetonitrile, followed by boc deprotection
(Figure 2A, Supplementary Materials Section 1). This activated Fua was then charged onto a tRNA for
decoding of the Met AUG elongator (i.e., not initiator) codon in a flexizyme (in this case eFx)-catalysed
reaction (Figure 2B). A similar process was used for N-acetyl Phe with the exception that a tRNA
specific for peptide initiation was used. Due to the fact that the acetyl-Phe residue is located at
the N-terminus, both unnatural residues are incorporated in response to the same codon (ATG),
a consequence of the difference between translation initiation and elongation. Addition of these
two unnatural amino-acid-charged tRNAs to an in vitro translation reaction deficient for Met thus
produced a genetic code in which N-acetyl Phe replaced the initiating Met, with Fua replacing any
downstream Met residues and all other codons encoding their cognate natural amino acid (Figure 2B,
Supplementary Materials Section 3).
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M + K+ (Da) 
1C AcFAGAFuaGPGCAGA 1056.43 / 1079.58 1095.55 
1H AcFAGAFuaGPGHAGA 1090.48 1091.66 1113.67 1129.68 
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Figure 2. Schematic representation of the flexible in vitro translation system used for expression of
furylalanine-containing peptides. On the left side (A), the structure and synthesis of the CME-activated
furylalanine is presented along with a simplified structure of the flexizyme eFx and a tRNA molecule
(green) (B). The translated peptides contained an N-acetylated Phe (red) at the N-terminus and a Fua
(blue), as well as a range of nucleophilic residues (brown). For all amino acid residues, one-letter codes
are used in this table except for furylalanine, abbreviated as Fua.
To confirm translation of the test te plates under the genetic code used (both described above),
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cases, and the M + H+ pe s ls f f r the ore easily protonated species (i.e., those including
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all be done in a single day.
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Table 1. MALDI-TOF analysis of the translated peptide library. For all amino acid residues, one-letter
codes are used in this table except for furylalanine, which is abbreviated as Fua. Color codes are in
accord with those used in Figure 2. “/”: not observed.
Peptide Name Peptide Name and Sequence Calculated ExactMass (Da) M + H
+ (Da) ExperimentalM + Na+ (Da) M + K
+ (Da)
1C AcFAGAFuaGPGCAGA 1056.43 / 1079.58 1095.55
1H AcFAGAFuaGPGHAGA 1090.48 1091.66 1113.67 1129.68
1K AcFAGAFuaGPGKAGA 1081.52 1082.69 1104.69 1120.66
1R AcFAGAFuaGPGRAGA 1109.53 1110.75 1132.71 1148.70
1S AcFAGAFuaGPGSAGA 1040.46 / 1063.65 1079.63
1Y AcFAGAFuaGPGYAGA 1116.49 / 1139.70 1155.69
3.2. NBS Oxidation of Furan-Containing Peptides Obtained through FIT
One of the advantages of the furan methodology relies in the fact that furan as such is not reactive
towards nucleophiles present in a biological system, but reactivity can be unveiled by oxidation.
Therefore, the translated, furan-containing peptides undergo an oxidation step prior to screening for
cyclisation reactions. In this work, N-bromosuccinimide (NBS) was used to selectively oxidize the
furan moiety in the template peptides [25], with oxidation and/or cyclisation being monitored by
MALDI-TOF. Since the furan moiety as well as the nucleophilic residue are present in a single peptide,
we carefully analysed the spectra for the presence of products resulting from potential intramolecular
reactions. In Table 2, the results of the MALDI-TOF analysis are shown (original mass spectra are
added in the Supplementary Materials Section 5).
Table 2. MALDI-TOF analysis of the oxidized template peptides after C-tip reverse phase purification.
Peptides 2 and their observed mass values are depicted in bold. “/”: not observed.
1 
 
 
 
 
 
Peptides 1
Peptides 2 M + H
+ M + Na+ M + K+ Other
1C
2C
/ / / 1214.97 (K+ + cysteinylation)
1230.97 (K+ + cysteinylation + 16)
1H
2H
/ / 1130.18
1146.21
/
1K
2K
1082.85 1105.13 1121.06
1137.09 1062.11 (M + H− 20 Da)
1R
2R
1111.13
1127.17
/ 1149.17 /
1S
2S
/ 1064.06 1080.00
1096.00 1021.43 (M + H− 20 Da)
1Y
2Y
/ / / 1313.91 (dibromination)
1329.87 (dibromination + 16)
For the Cys-containing template peptide 1C, the original protonated mass was not observed
(nor were sodium or potassium adducts), but a new cysteinylation product (1214.97 Da) was detected
in addition to its furan oxidation product +16 Da (1230.97 Da). While the Cys thiol moiety is the
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most nucleophilic functional group tested, these results suggest that under the oxidizing conditions
used for formation of the keto-enal group, disulphide bond formation between the peptide Cys and
free Cys in solution prevents reaction with the oxidized furan. In the case of the His-containing
template peptide 1H, next to the potassium adduct of 1H, also the furan oxidation product 2H was
identified, but no product resulting from a potential cyclization was observed. The mass spectrum for
the Arg-containing template peptide 1R showed the M + H+ peak as well as the potassium adduct
(M + K+), along with a product resulting from oxidation 2R. For the Tyr-containing peptide 1Y, a mass
corresponding to dibromination of Tyr in the starting peptide as well as the furan oxidation product
thereof were observed, not unexpected due to the use of a huge excess of NBS. For the Lys- as well
as Ser-containing template peptides 1K and 1S, we observed the sodium and potassium adducts of
the starting peptides as well as the potassium adduct of the furan oxidation product. Additionally,
in both cases, a particular signal corresponding to M + H − 20 Da was detected (highlighted in grey in
Table 2). This observation of a reduced mass could indicate, for example, an oxidation (resulting in
a peptide mass M + 16), followed by an intramolecular cyclization reaction accompanied by the loss
of water (resulting in a peptide mass M + 16 − 18), and an additional loss of water during ionisation
(M + 16 − 18 − 18 = M − 20).
3.3. Peptide Scale up by SPPS and Subsequent NBS Oxidation
Based on the results of the FIT screening, the Lys- and Ser-containing template peptides 1K and
1S were resynthesized via solid-phase peptide synthesis (SPPS) in order to generate sufficient material
for more detailed characterisation of the reaction following oxidation (see Supplementary Materials
Section 6). In addition, a control peptide with a Gly residue rather than a nucleophilic residue was
synthesized. Similar to the FIT screening, the peptides were treated with NBS to oxidize the furan
moiety. To render the oxidized furan moiety more electrophilic and to promote imine formation (in the
case of peptide 2K), this reaction was performed in the presence of NaOAc buffer of pH 5.2 as per
Malins et al. [17]. In Figure 3, the structure of the three resulting peptides is shown (top) with the LC
chromatogram (red) as well as the MS spectrum corresponding to the oxidation peak (bottom) for each
of the peptides.
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three oxidized peptides.
r t ing to the LC signal of the product formed upon oxidation,
eac ti ass of −2 Da compared to the M + H+ m ss can b observed for the three peptides.
This is 18 Da lower than the expected +16 Da mass for the oxidation product (Figure 3), which can
be explained by oxidati n of the furan moiety followed by l ss of water (+16 Da − 18 Da = −2 Da).
The obtained mass data should, however, be interpreted with care. Indeed, the observed loss of water
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can be the result of an intramolecular reaction, thus indicating formation of a new species resulting
from a cyclisation event, but can also occur during the ionisation (the signal thus corresponding to the
oxidized product without further cyclisation). To determine whether the M + H+ − 2 Da peak and
the M + H+ + 16 Da peak originated from one and the same compound in the LC, the chromatograms
for both extracted ions (−2 Da and +16 Da) were compared. The results indicated that for peptides
2G and 2S, both ions originated from the same (oxidized but not cyclized) compound in the LC,
indicating that the M + H+ − 2 Da peaks resulted from the ionisation process and were artefacts
of mass spectrometry. However, for peptide 2K, it was clear that the M + H+ − 2 Da and M + H+
+ 16 Da ions originated from different products, implying that the M + H+ − 2 Da peak may be
due to imine formation (see Supplementary Materials Section 7 for complete chromatograms and
extracted ion chromatograms). It should be noted that in the chromatogram of the Ser-containing
peptide template, a substantial amount of native (nonoxidized) peptide was observed, resulting from
incomplete oxidation due to a greater amount of starting material in this case.
3.4. Identification of a Pyrrole Moiety as Cyclisation Motif
To quench the rather labile imine-constrained peptide (Figure 4, peptide 2Ka), we decided to try
and reduce it to the corresponding secondary amine with sodium cyanoborohydride. This reduction
would theoretically result in a product with the same mass as the original peptide. However,
MS analysis of the sample, in which NBS oxidation was followed by NaCNBH3 reduction, revealed the
presence of a compound with a mass corresponding to M + H+ − 18 Da (Figure 4). This mass can be
explained by an additional subsequent attack of the formed amine (upon reduction) on the remaining
keto functionality followed by aromatization through loss of water (see Supplementary Materials
Section 8).
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right (a) corresponds to the starting peptide whic was not oxidized. Signal b in part B of Figure 4 can
be correlated to oxi ation products. The MS spectrum of peak b indicates two products, the expected
oxidized peptide with a mass of 1098.30 Da and a product with the mass of the starting peptide.
This last product can be explained by the fact that oxidation took place and an imine was formed
Biomedicines 2018, 6, 99 9 of 12
(with loss of water) which was further reduced to a secondary amine upon NaBH3CN treatment
without further reaction to the pyrrole-constrained peptide. Finally, the MS spectrum of peak c shows
a mass of 1064.25 Da, which can be correlated with the formation of a pyrrole-constrained peptide.
We decided to further explore the scope of this pyrrole-based cyclisation while at the same time
generating additional structural evidence for formation of the pyrrole moiety as cyclisation element.
3.5. Extending the Scope of Pyrrole-Mediated Cyclisation: Varying the Positioning and Conformation within
the Template Peptide
The original template peptide used in this work featured a Pro positioned in between the Fua
and the Lys, resulting in a form of preorganisation of the peptide conformation inducing proximity
between the reactive moieties. To demonstrate that the pyrrole-constrained peptide formation is not
limited to the specific peptide sequence chosen here, two additional variants were synthesized via
SPPS (Figure 5, Supplementary Materials Section 9). In one of these (peptide 4K), the distance between
the two reacting residues was increased by interchanging both Fua and Lys with a neighbouring Ala.
On the other hand, in peptide 5K, the internal Pro residue was replaced by an Ala.
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4K and 5K, and LCMS data for the oxidation and reductio reactions tow rds the cyclic peptides 6K
and 7K are included in the Supplementary Materials (Figures S10.1–S10.3). Thes one-pot oxidation and
reduction reac s were also repeated at larger sc le for p ide 4K to allow structural characterisation
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(peptide 6K) was p rified by RP-HPLC and after l ophilization, the p oduct was resolubilize in
90/10 H2O/D2O for NMR analysis on a 700 MHz (Bruker) spectrometer, confirming the structure of
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The N-termini of the peptides used in this study were masked to allow investigating the reactivity
of natural nucleophilic amino acid side chains. As the N-terminal amine is more reactive than the
ε-amino group of the lysine side chain, we expect that also pyrrole-constrained head-to-side-chain
peptides can potentially be generated through this method.
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